Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ab Trill currently holds 8,825,742 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ab Trill has been a net buyer of DMAC stock. They have purchased $7.6M and sold $0 worth of shares.
Ab Trill's most recent insider trade was on Nov 25, 2025, when they purchased 73,099 shares at $8.57 per share.
Ab Trill serves as Executive at DiaMedica Therapeutics Inc. (DMAC). They have executed 7 insider transactions totaling $7.6M over their tenure at the company.
Ab Trill holds the position of Executive at DiaMedica Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Ab Trill has shown a buying trading pattern, with $7.6M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ab Trill was on Nov 19, 2025, when they purchased $1.7M worth of DMAC shares. This transaction involved 240,352 shares at $7.21 per share.
Ab Trill currently owns 8,825,742 shares of DiaMedica Therapeutics Inc. (DMAC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ab Trill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ab Trill has 7 Form 4 filings on record as an insider at DiaMedica Therapeutics Inc..
Set alerts for Ab Trill and 40,000+ other insiders.